AAAAAA

   
Results: 1-9 |
Results: 9
LYSOPHOSPHATIDYLCHOLINE IS INVOLVED IN THE ANTIGENICITY OF OXIDIZED LDL
Authors: WU RH HUANG YH ELINDER LS FROSTEGARD J
Citation: Rh. Wu et al., LYSOPHOSPHATIDYLCHOLINE IS INVOLVED IN THE ANTIGENICITY OF OXIDIZED LDL, Arteriosclerosis, thrombosis, and vascular biology, 18(4), 1998, pp. 626-630
EXPRESSION OF PHOSPHOLIPASE A(2) ISOFORMS IN HUMAN NORMAL AND ATHEROSCLEROTIC ARTERIAL-WALL
Authors: ELINDER LS DUMITRESCU A LARSSON P HEDIN U FROSTEGARD J CLAESSON HE
Citation: Ls. Elinder et al., EXPRESSION OF PHOSPHOLIPASE A(2) ISOFORMS IN HUMAN NORMAL AND ATHEROSCLEROTIC ARTERIAL-WALL, Arteriosclerosis, thrombosis, and vascular biology, 17(10), 1997, pp. 2257-2263
ANTIOXIDANT STATE AND MORTALITY FROM CORONARY HEART-DISEASE IN LITHUANIAN AND SWEDISH MEN - CONCOMITANT CROSS-SECTIONAL STUDY OF MEN AGED 50
Authors: KRISTENSON M ZIEDEN B KUCINSKIENE Z ELINDER LS BERGDAHL B ELWING B ABARAVICIUS A RAZINKOVIENE L CALKAUSKAS H OLSSON AG
Citation: M. Kristenson et al., ANTIOXIDANT STATE AND MORTALITY FROM CORONARY HEART-DISEASE IN LITHUANIAN AND SWEDISH MEN - CONCOMITANT CROSS-SECTIONAL STUDY OF MEN AGED 50, BMJ. British medical journal, 314(7081), 1997, pp. 629-633
CYTOKINE-STIMULATORY PROPERTIES OF PHOSPHOLIPIDS AND OXIDIZED LDL AREMEDIATED BY THE PAF RECEPTOR
Authors: ELINDER LS HUANG YH FROSTEGARD J
Citation: Ls. Elinder et al., CYTOKINE-STIMULATORY PROPERTIES OF PHOSPHOLIPIDS AND OXIDIZED LDL AREMEDIATED BY THE PAF RECEPTOR, Atherosclerosis, 134(1-2), 1997, pp. 283-283
THE EFFECT OF PROBUCOL ON LOW-DENSITY-LIPOPROTEIN OXIDATION AND FEMORAL ATHEROSCLEROSIS
Authors: REGNSTROM J WALLDIUS G NILSSON S ELINDER LS JOHANSSON J MOLGAARD J HOLME I OLSSON AG NILSSON J
Citation: J. Regnstrom et al., THE EFFECT OF PROBUCOL ON LOW-DENSITY-LIPOPROTEIN OXIDATION AND FEMORAL ATHEROSCLEROSIS, Atherosclerosis, 125(2), 1996, pp. 217-229
LOWERING OF HDL(2B) BY PROBUCOL PARTLY EXPLAINS THE FAILURE OF THE DRUG TO AFFECT FEMORAL ATHEROSCLEROSIS IN SUBJECTS WITH HYPERCHOLESTEROLEMIA - A PROBUCOL QUANTITATIVE REGRESSION SWEDISH TRIAL (PQRST) REPORT
Authors: JOHANSSON J OLSSON AG BERGSTRAND L ELINDER LS NILSSON S ERIKSON U MOLGAARD J HOLME I WALLDIUS G
Citation: J. Johansson et al., LOWERING OF HDL(2B) BY PROBUCOL PARTLY EXPLAINS THE FAILURE OF THE DRUG TO AFFECT FEMORAL ATHEROSCLEROSIS IN SUBJECTS WITH HYPERCHOLESTEROLEMIA - A PROBUCOL QUANTITATIVE REGRESSION SWEDISH TRIAL (PQRST) REPORT, Arteriosclerosis, thrombosis, and vascular biology, 15(8), 1995, pp. 1049-1056
PROBUCOL TREATMENT DECREASES SERUM CONCENTRATIONS OF DIET-DERIVED ANTIOXIDANTS
Authors: ELINDER LS HADELL K JOHANSSON J MOLGAARD J HOLME I OLSSON AG WALLDIUS G
Citation: Ls. Elinder et al., PROBUCOL TREATMENT DECREASES SERUM CONCENTRATIONS OF DIET-DERIVED ANTIOXIDANTS, Arteriosclerosis, thrombosis, and vascular biology, 15(8), 1995, pp. 1057-1063
EFFECT OF THE ANTIOXIDANT PROBUCOL ON TRANSPLANT ARTERIOSCLEROSIS IN AORTA ALLOGRAFTED RABBITS
Authors: ANDERSEN HO HOLM P NORDESTGAARD BG HANSEN BF KJELDSEN K ELINDER LS STENDER S
Citation: Ho. Andersen et al., EFFECT OF THE ANTIOXIDANT PROBUCOL ON TRANSPLANT ARTERIOSCLEROSIS IN AORTA ALLOGRAFTED RABBITS, Journal of Molecular and Cellular Cardiology, 27(8), 1995, pp. 1561-1571
SERUM LIPID-SOLUBLE ANTIOXIDANTS IN PATIENTS WITH HYPERLIPOPROTEINEMIA
Authors: ELINDER LS HADELL K JOHANSSON J MOLGAARD J OLSSON AG WALLDIUS G
Citation: Ls. Elinder et al., SERUM LIPID-SOLUBLE ANTIOXIDANTS IN PATIENTS WITH HYPERLIPOPROTEINEMIA, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 4(4), 1994, pp. 197-203
Risultati: 1-9 |